Replimune Group, Inc. · NASDAQ:REPL
T. Rowe Price Associates Inc reported a 10.60% stake in Replimune Group, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
T. Rowe Price Associates Inc reported a 10.60% stake in Replimune Group, Inc., 8,306,757 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 10.60%
- Shares
- 8,306,757
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 10.60% | 8,306,757 |
Source
Related
- Replimune Group, Inc.
- T. Rowe Price Associates Inc
- Replimune Group, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · May 7, 2026
- Form 4 · Astley-Sparke Philip · Aug 24, 2026
- Form 4 · Hill Emily Luisa · Aug 19, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Aug 14, 2026
- Form 4 · Patel Sushil · Aug 12, 2026
- Form 4 · Hill Emily Luisa · Aug 12, 2026